Cinagen-D 0.5%+0.1% (Ophthalmic Solution)
5 ml drop: ৳ 200.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Moxifloxacin hydrochloride dexamethasone |
| Company | Navana pharmaceuticals ltd |
Indications
- Treatment of eye infections
- Prevention of inflammation after eye surgery
- Treatment of bacterial infection after eye surgery
Composition
- Moxifloxacin 5 mg per ml
- Dexamethasone 1 mg per ml
Mode of action
- Moxifloxacin inhibits topoisomerase II and IV
- Dexamethasone is anti-allergic and anti-exudative
Dosage & Administration
- Instill 1 drop 4 times a day for prevention of infection and post-surgical ocular inflammation
- Instill the medication immediately after eye surgery for cataract surgery
- Instill the medication at least 15 minutes after ocular surgery for patients undergoing LASIK refractive surgery
- Instill 1 drop 4 times a day for up to 7 days in eye infections caused by susceptible microorganisms
Contraindications
- Hypersensitivity to other quinolones
- Glaucoma
- Ocular disease causing thinning of the cornea or sclera
- Inflammation in the eye caused by virus, fungi or mycobacteria
- Epithelial herpes simplex keratitis
- Mycobacterial infection of the eye
- Fungal diseases of ocular structures
Side Effects
- Conjunctivitis
- Decreased visual acuity
- Dry eye
- Keratitis
- Ocular discomfort
- Hyperemia
- Pain
- Subconjunctival hemorrhage
- Tearing
- Visual acuity & field defects
- Cataract formation
- Secondary ocular infection following suppression of host response
- Perforation of the globe
Pregnancy & Lactation
- Use during pregnancy only if potential benefit justifies potential risk to the fetus
- Caution advised when used by nursing women
Precautions & Warnings
- Discontinue use if allergic reaction occurs
- Prolonged steroid use may result in ocular hypertension and/or glaucoma
- Routine evaluation of intraocular pressure
- Perforations have been known to occur with use of topical corticosteroids in diseases causing thinning of the cornea or sclera
- Steroids may mask or enhance existing infection in acute purulent conditions of the eye
Use in Special Populations
- No change in dosage required in elderly patients
- Efficacy and safety not established in pediatric patients
Overdose Effects
- No information available on overdosage
Therapeutic Class
- Ophthalmic steroid preparations
Storage Conditions
- Store in a cool place below 30°C
- Protect from light
- Once opened, use within 28 days and store at room temperature up to 30°C
- Discard after 28 days
- Keep out of reach of children
Related Brands
- Moxquin D 0.5%+0.1% (Ophthalmic Solution) - incepta-pharmaceuticals-ltd
- Flomox D 0.5%+0.1% (Ophthalmic Solution) - osl-pharma-limited
- Eyemox-D 0.5%+0.1% (Ophthalmic Solution) - acme-laboratories-ltd
- Moxlocin D 0.5%+0.1% (Ophthalmic Solution) - pacific-pharmaceuticals-ltd
- Moxilocin D 0.5%+0.1% (Ophthalmic Solution) - opsonin-pharma-ltd